7.3.3.2. Passive Immunization
Table of Contents
Passive immunization is a way of protecting an organism by giving it finished, ready‑made components of the specific immune response—usually antibodies—rather than stimulating it to make its own. In contrast to active immunization, no immunological memory is formed; the effect is fast but temporary.
Principles of Passive Immunization
In passive immunization, specific immune products are transferred from a donor to a recipient:
- The recipient is not (or is only minimally) involved in producing the immune response.
- The donor has previously formed antibodies (or antibody‑like molecules) against a particular antigen.
- The transferred substances act immediately against the pathogen or toxin.
Typically, these products are:
- Antibodies (immunoglobulins), often purified from blood plasma.
- In special modern approaches, monoclonal antibodies produced in cell culture.
The key features:
- Rapid onset: Antibodies are present and effective almost immediately after administration.
- Short duration: As the foreign antibodies are broken down, the protection disappears; there is practically no long‑term immunological memory.
- No primary response in the recipient: The recipient’s B and T lymphocytes are not activated as they would be in active immunization.
Natural and Artificial Passive Immunization
Natural Passive Immunization
This occurs without medical intervention, through physiological transfer of antibodies:
- Via the placenta: In many mammals, including humans, maternal IgG antibodies cross the placenta and enter the fetal circulation before birth.
- The newborn is temporarily protected against pathogens to which the mother has immunity.
- The protection wanes as maternal antibodies are degraded in the infant’s body.
- Via breast milk: Colostrum and early breast milk contain high levels of IgA and other antibodies.
- These antibodies protect the infant’s mucous membranes (e.g., gut) from pathogens, especially during the first months of life.
Natural passive immunization is particularly important because:
- The infant’s own specific immune response is not yet fully developed.
- It bridges the vulnerable period before active immunizations and the child’s own immune memory are fully established.
Artificial Passive Immunization
Here, antibodies are intentionally administered as a medical measure:
- Source of antibodies:
- Human donors (e.g., convalescent plasma or pooled immunoglobulin).
- Immunized animals (e.g., horses) for certain antivenoms and antitoxins.
- Biotechnological production (monoclonal antibodies).
- Forms:
- Specific immune globulins: Concentrated antibodies against a particular pathogen or toxin (e.g., hepatitis B immune globulin).
- Normal immune globulins: Mixed antibodies from many donors, providing broad, nonspecific support (e.g., in some immune deficiencies).
- Antitoxins and antivenoms: Antibodies directed against toxins (e.g., tetanus antitoxin, snake antivenom).
Artificial passive immunization is always time‑limited in its effect, but can be life‑saving in acute situations.
Mechanisms of Action
The transferred antibodies can:
- Neutralize toxins and viruses
- Bind directly to toxins (e.g., tetanus toxin, snake venom components), preventing them from interacting with target cells.
- Bind virus particles, blocking entry into host cells.
- Opsonize pathogens
- Coat bacteria or other microbes, making them easier for phagocytes to recognize and ingest.
- Activate complement (depending on antibody type)
- Promote complement‑mediated lysis of pathogens or enhance phagocytosis.
- Block pathogen binding sites
- Occupy structures on microbes or host cells needed for attachment, thus preventing infection or spread.
These mechanisms are identical to the functions of antibodies formed during a normal immune response; the difference lies only in the origin of the antibodies.
Indications and Typical Use Cases
Passive immunization is indicated when:
- Immediate protection is required (no time for active immunization to take effect).
- A high‑risk exposure has already occurred (post‑exposure).
- The patient is unable to mount a sufficient immune response, for example due to certain immunodeficiencies.
Examples of situations where passive immunization is used:
- Tetanus risk after injury
- If a person with uncertain or incomplete vaccination status suffers a deep or contaminated wound, tetanus immunoglobulin can be administered.
- Frequently combined with active immunization (see below).
- Rabies exposure
- After bites by animals suspected of carrying rabies, rabies immune globulin is given as quickly as possible around the wound and intramuscularly.
- Usually combined with rabies vaccination (active immunization).
- Hepatitis B exposure
- Newborns of mothers with active hepatitis B infection receive hepatitis B immune globulin soon after birth, often together with vaccination.
- Also used after needle‑stick injuries or sexual exposure in unvaccinated persons.
- Certain viral diseases
- Specific immunoglobulins can be used in special cases (e.g., varicella‑zoster immunoglobulin for particularly at‑risk individuals after exposure).
- Toxins and venoms
- Antivenoms for snake, scorpion, or spider bites.
- Antitoxins for botulism or diphtheria.
- Immune deficiencies
- Regular infusions of pooled immunoglobulins to support patients with antibody production defects.
In all these cases, the goal is immediate neutralization or mitigation of the pathogen or toxin to prevent disease or reduce its severity.
Duration of Protection and Lack of Memory
Passive immunity is temporary:
- Antibodies are proteins and are gradually broken down in the body.
- Typical half‑life of IgG in humans is on the order of weeks.
- As the antibody concentration declines, so does protective effect.
Crucially:
- No memory cells (B or T lymphocytes with long‑term memory) are generated in the recipient.
- Once the transferred antibodies are gone, the immune system is no better “prepared” than before.
Therefore, passive immunization:
- Does not replace full vaccination schedules.
- Is used as an acute measure or as a bridge until active immunization becomes effective.
Combined Passive–Active Immunization
In some situations, passive and active immunization are used together:
- Goal:
- Immediate protection through passive immunization.
- Long‑term protection through active immunization.
- Typical example:
- A person at risk for tetanus who is not fully vaccinated:
- Receives tetanus immune globulin (passive) for immediate neutralization of any possible toxin.
- Simultaneously receives tetanus vaccine (active) so that their own immune system can build memory.
Important practical aspects:
- The antibodies from passive immunization can, in high amounts, partially neutralize the vaccine antigen.
- The administration of immunoglobulin and vaccine is therefore often done at different injection sites and possibly with adjusted timing, depending on the preparation.
Risks and Side Effects
While generally useful and often life‑saving, passive immunization carries specific risks:
- Allergic reactions
- Especially when antibodies originate from animals (e.g., horse serum) rather than humans.
- Can range from local reactions to severe anaphylactic shock.
- Serum sickness
- A delayed immune reaction against the foreign proteins in the serum.
- Symptoms can include fever, skin rashes, joint pain, and swollen lymph nodes.
- Interference with active vaccination
- Transferred antibodies can neutralize live attenuated vaccines or other vaccine antigens if administered too closely in time.
- Vaccination schedules and timing must be carefully coordinated.
- Transmission risks (for human blood products)
- Modern processing and testing greatly reduce the risk of transmitting blood‑borne pathogens, but the potential exists and must be managed.
For these reasons:
- Human-derived immunoglobulins are preferred when possible.
- Patients must be monitored after administration, especially after animal-derived antivenoms or antitoxins.
Advantages and Limitations at a Glance
Advantages:
- Very rapid protective effect.
- Can be life‑saving in acute exposure to dangerous pathogens or toxins.
- Useful in individuals with impaired immune systems.
Limitations:
- Protection is transient; no immunological memory.
- Production is complex and costly (needs donors or biotechnological facilities).
- Risk of allergic reactions and serum sickness, particularly with non‑human antibodies.
- Possible interference with certain vaccinations.
Passive immunization is thus best understood as a targeted emergency tool and as supportive therapy, ideally combined with active immunization strategies that provide lasting protection.
Views: 0
Where to Move
Move chapter:
- ☰ 1. Biology as the Science of Living Organisms
- ☰ 1.1. The Biological Age
- ☰ 1.1.1. Biology Determines Our Lives
- ☰ 1.1.2. Characteristics of Living Things
- ☰ 1.1.3. Organization of the Living
-
- ☰ 1.2. The Development of Biology as a Science
- ☰ 1.2.1. Beginnings in Antiquity
- ☰ 1.2.2. A New Beginning in the Renaissance
- ☰ 1.2.3. The Enlightenment
- ☰ 1.2.4. Recording Biological Diversity
- ☰ 1.2.5. Vitalism and Mechanism
- ☰ 1.2.6. Evolutionary Theory and Its Consequences
- ☰ 1.2.7. Molecular Foundations
- ☰ 1.2.8. Global Interrelationships and the Gaia Hypothesis
-
- ☰ 1.3. Biological Sciences
- ☰ 1.3.1. Subdisciplines of the Biological Sciences
- ☰ 1.3.2. Ways of Thinking and Working in Biology
- ☰ 1.3.2.1. Searching for, Evaluating, Processing, and Presenting Information
- ☰ 1.3.2.2. Induction and Deduction
-
- ☰ 1.3.3. Relationships to Other Natural Sciences
- ☰ 1.3.4. Relationships to the Humanities
- ☰ 1.3.5. Interdisciplinary Fields
-
-
- ☰ 2. Basic Building Blocks of Life
- ☰ 2.1. Carbon as the Element of Life
- ☰ 2.1.1. The Periodic Table of the Elements
- ☰ 2.1.1.1. Types of Chemical Bonds
-
- ☰ 2.1.2. Carbon as an Element
- ☰ 2.1.3. Possible Carbon Compounds
-
- ☰ 2.2. Water as the Medium of Life
- ☰ 2.2.1. Properties of Water
- ☰ 2.2.2. Autoprotolysis of Water
-
- ☰ 2.3. Macromolecules
- ☰ 2.3.1. Proteins and Their Structure
- ☰ 2.3.2. Carbohydrates
- ☰ 2.3.2.1. Monosaccharides
- ☰ 2.3.2.2. Disaccharides
- ☰ 2.3.2.3. Polysaccharides
-
- ☰ 2.3.3. Lipids
- ☰ 2.3.4. Nucleic Acids
- ☰ 2.3.5. Other Important Molecules
- ☰ 2.3.5.1. Pyrrole Compounds
- ☰ 2.3.5.2. Terpenes – Isoprenoids
-
-
- ☰ 2.4. Cells and Cell Components
- ☰ 2.4.1. The Cell as the Basic Unit of Life
- ☰ 2.4.2. Basic Structures: Membrane, Fibril, Granum
- ☰ 2.4.3. The Prokaryotic Cell (Procyte)
- ☰ 2.4.4. The Eukaryotic Cell (Eucyte): The Cell of Eukaryotes
- ☰ 2.4.5. Viruses, Viroids, and Prions
-
- ☰ 2.5. From Cells to Tissues and Organs
- ☰ 2.5.1. Nuclear and Cell Division
- ☰ 2.5.2. Unicellular and Multicellular Organisms
-
-
- ☰ 3. Metabolism and Energy Conversion
- ☰ 3.1. Energy Conversion in Metabolic Processes
- ☰ 3.1.1. Metabolic Pathways
- ☰ 3.1.2. Organisms Live on Free Energy
- ☰ 3.1.2.1. Thermodynamic Equilibrium and Free Energy
- ☰ 3.1.2.2. Steady State
-
- ☰ 3.1.3. ATP: Energy Carrier in Cells or Organisms
- ☰ 3.1.3.1. ATP Regeneration
-
- ☰ 3.1.4. Determining Energy Conversion
- ☰ 3.1.4.1. Metabolic Rate
- ☰ 3.1.4.2. Direct Calorimetry
- ☰ 3.1.4.3. Indirect Calorimetry (Respirometry)
- ☰ 3.1.4.4. Basal Metabolic Rate and Performance Metabolism
-
-
- ☰ 3.2. Enzymes as Catalysts in the Organism
- ☰ 3.2.1. Course of Enzymatic Reactions
- ☰ 3.2.2. Structure and Function of Enzymes
- ☰ 3.2.3. Enzyme Activity
- ☰ 3.2.3.1. Influence of Temperature
- ☰ 3.2.3.2. Influence of pH
- ☰ 3.2.3.3. Concentration
- ☰ 3.2.3.4. Enzyme Regulation
- ☰ 3.2.3.5. Importance of Enzymes
-
-
- ☰ 3.3. Anabolic Metabolism
- ☰ 3.3.1. Photosynthesis
- ☰ 3.3.1.1. Location of Photosynthesis: Fine Structure of Chloroplasts
- ☰ 3.3.1.2. Structure of the Photosystems
- ☰ 3.3.1.3. Process of Photosynthesis: Light-Dependent Reactions
- ☰ 3.3.1.4. Light-Independent Reactions (Dark Reaction, Calvin Cycle)
- ☰ 3.3.1.5. Sequence of the Light-Dependent Reactions
- ☰ 3.3.1.6. Factors Influencing Photosynthesis
-
- ☰ 3.3.2. Chemolithoautotrophy (Chemosynthesis)
- ☰ 3.3.3. Storage of Chemical Energy
-
- ☰ 3.4. Catabolic Metabolism
- ☰ 3.4.1. Cellular Respiration
- ☰ 3.4.1.1. Glycolysis
- ☰ 3.4.1.2. Transport of Pyruvate and Formation of Acetyl-CoA
- ☰ 3.4.1.3. Citric Acid Cycle (Krebs Cycle)
- ☰ 3.4.1.4. Electron Transport Chain
-
- ☰ 3.4.2. Fermentation as Energy Release Without Oxygen
-
- ☰ 3.5. Transport Processes in Plants
- ☰ 3.5.1. Basic Components of the Plant
- ☰ 3.5.2. Uptake of Water and Mineral Salts
- ☰ 3.5.3. Water and Ion Transport in the Stem
- ☰ 3.5.4. Regulation of Transpiration
- ☰ 3.5.5. Transport of Organic Substances
-
- ☰ 3.6. Digestion, Respiration, and Transport in Animals
- ☰ 3.6.1. Respiration and Respiratory Organs
- ☰ 3.6.2. Heart and Circulatory System
- ☰ 3.6.2.1. Gas Exchange in Lungs and Tissues
- ☰ 3.6.2.2. Transport of Carbon Dioxide
-
- ☰ 3.6.3. Excretory Organs and Excretion
- ☰ 3.6.3.1. Structure and Function of the Human Kidney
- ☰ 3.6.3.2. Formation of Urine in the Nephron
-
-
-
- ☰ 4. Control, Regulation, and Information Processing
- ☰ 4.1. Excitation and Conduction
- ☰ 4.1.1. Biological Basics
- ☰ 4.1.2. Excitability and Response in Algae and Plants
- ☰ 4.1.3. Excitability of Animal Cells
- ☰ 4.1.4. Conduction of Excitation
- ☰ 4.1.5. Transmission of Excitation Between Excitable Cells
- ☰ 4.1.6. From Stimulus Reception to Response
-
- ☰ 4.2. Sense Organs
- ☰ 4.2.1. Mediators Between Organism and Environment
- ☰ 4.2.2. Visual Sense
- ☰ 4.2.3. Hearing Sense
- ☰ 4.2.4. Sense of Balance
- ☰ 4.2.5. Skin Senses
- ☰ 4.2.6. Chemical Sense
- ☰ 4.2.7. Electrical Sense and Magnetic Sense
-
- ☰ 4.3. Information Processing and Storage
- ☰ 4.3.1. Nervous Systems of Invertebrates
- ☰ 4.3.2. Nervous Systems of Vertebrates
- ☰ 4.3.3. Memory, Language, Consciousness
- ☰ 4.3.4. Sleep
- ☰ 4.3.5. Psychoactive Substances and Neurotoxins
- ☰ 4.3.6. Muscles and Movement
- ☰ 4.3.7. Function of Muscle Cells
- ☰ 4.3.8. Muscle Movement
-
- ☰ 4.4. Hormones
- ☰ 4.4.1. The Endocrine System of Vertebrates and Humans
- ☰ 4.4.1.1. Classification of Hormones
-
- ☰ 4.4.2. Coupling of Nervous and Endocrine Systems
- ☰ 4.4.3. The Endocrine System of Invertebrates
- ☰ 4.4.4. Plant Hormones
- ☰ 4.4.5. Pheromones
-
-
- ☰ 5. Reproduction, Growth, Development
- ☰ 5.1. Reproduction
- ☰ 5.1.1. Reproduction and Nutrition
- ☰ 5.1.2. Asexual Reproduction
- ☰ 5.1.3. Sexual Reproduction
-
- ☰ 5.2. Lower Organisms
- ☰ 5.2.1. Prokaryotes
- ☰ 5.2.2. Protists
- ☰ 5.2.3. Fungi
-
- ☰ 5.3. Plants
- ☰ 5.3.1. Growth and Differentiation
- ☰ 5.3.2. Reproduction Techniques
-
- ☰ 5.4. Animals and Humans
- ☰ 5.4.1. Embryonic Development in Animals
- ☰ 5.4.2. Embryonic Development in Humans
- ☰ 5.4.3. Developmental Disorders and Reproductive Technologies
-
-
- ☰ 6. Genetics
- ☰ 6.1. Molecular Foundations of Heredity
- ☰ 6.1.1. Nucleic Acids as Carriers of Genetic Information
- ☰ 6.1.1.1. Structure of DNA
- ☰ 6.1.1.2. Genetic Code
- ☰ 6.1.1.3. Ribonucleic Acid (RNA)
-
- ☰ 6.1.2. Identical Replicators
- ☰ 6.1.3. From Gene to Protein
- ☰ 6.1.3.1. Protein Biosynthesis in Prokaryotes and Eukaryotes
-
- ☰ 6.1.4. Regulation of Gene Activity
- ☰ 6.1.4.1. Transcriptional Control in Prokaryotes
- ☰ 6.1.4.2. Regulation of Gene Activity in Eukaryotes
-
- ☰ 6.1.5. Modification
- ☰ 6.1.5.1. Continuous Variation
- ☰ 6.1.5.2. Discontinuous Variation
- ☰ 6.1.5.3. Modificatory (Phenotypic) Sex Determination
-
- ☰ 6.1.6. Mutation
- ☰ 6.1.6.1. Causes of Mutations
- ☰ 6.1.6.2. Types of Mutations
-
-
- ☰ 6.2. Inheritance Rules and Their Applications
- ☰ 6.2.1. Mendelian Laws of Inheritance
- ☰ 6.2.1.1. Mendel’s Crossbreeding Experiments
- ☰ 6.2.1.2. Dominant – Recessive – Intermediate
- ☰ 6.2.1.3. Mendelian Terminology
-
- ☰ 6.2.2. Chromosome Theory of Inheritance
- ☰ 6.2.2.1. Gene Linkage
-
- ☰ 6.2.3. Inheritance in Humans
- ☰ 6.2.3.1. Genotypic Sex Determination in Humans
- ☰ 6.2.3.2. Barr Body and Lyon Hypothesis
-
- ☰ 6.2.4. Gene Mutations in Humans
- ☰ 6.2.4.1. X-linked Recessive Genetic Disorders
- ☰ 6.2.4.2. Autosomal Genetic Disorders
-
- ☰ 6.2.5. Chromosomal Aberrations in Humans
- ☰ 6.2.5.1. Sex Chromosome Aberrations in Humans
-
-
- ☰ 6.3. Genetic Engineering
- ☰ 6.3.1. Basics of Genetic Engineering
- ☰ 6.3.1.1. Selected Aspects of Viral and Bacterial Genetics
- ☰ 6.3.1.2. Bacteriophages
- ☰ 6.3.1.3. Retroviruses Contradict the Central Dogma
- ☰ 6.3.1.4. Bacteria
-
- ☰ 6.3.2. Methods of Investigation
- ☰ 6.3.2.1. Restriction Enzymes and Ligases
- ☰ 6.3.2.2. Gel Electrophoresis
- ☰ 6.3.2.3. Hybridization
- ☰ 6.3.2.4. Polymerase Chain Reaction (PCR)
- ☰ 6.3.2.5. DNA Sequencing
- ☰ 6.3.2.6. Transfer of Foreign Genetic Material
-
- ☰ 6.3.3. Applications of Genetics
- ☰ 6.3.4. Gene Mapping
- ☰ 6.3.5. Gene Therapy
-
-
- ☰ 7. Disease and Health
- ☰ 7.1. Terms and Definitions
- ☰ 7.1.1. Health
- ☰ 7.1.2. Disease
-
- ☰ 7.2. Infectious Diseases in Humans
- ☰ 7.2.1. Transmission and Course of Infectious Diseases
- ☰ 7.2.2. Subviral Structures as Pathogens
- ☰ 7.2.2.1. Viroids
- ☰ 7.2.2.2. Prions
-
- ☰ 7.2.3. Viruses as Pathogens
- ☰ 7.2.3.1. Human Immunodeficiency Virus (HIV)
-
- ☰ 7.2.4. Bacteria as Pathogens
- ☰ 7.2.4.1. Plague Pathogen
- ☰ 7.2.4.2. Salmonella
-
- ☰ 7.2.5. Fungi as Pathogens
- ☰ 7.2.5.1. Yeasts
- ☰ 7.2.5.2. Dermatophytes
-
- ☰ 7.2.6. Protists as Pathogens
- ☰ 7.2.6.1. Malaria Pathogen
-
- ☰ 7.2.7. Animals as Pathogens
- ☰ 7.2.7.1. Pinworm (Enterobius vermicularis)
- ☰ 7.2.7.2. Mites as Agents of Scabies
-
-
- ☰ 7.3. Immunobiology
- ☰ 7.3.1. Nonspecific Immune Response
- ☰ 7.3.1.1. Passive Resistance: General Defense
- ☰ 7.3.1.2. Active Resistance
-
- ☰ 7.3.2. Specific Immune Response
- ☰ 7.3.2.1. Antibodies
-
- ☰ 7.3.3. Active and Passive Immunization
- ☰ 7.3.3.1. Active Immunization
- ☰ 7.3.3.2. Passive Immunization
-
- ☰ 7.3.4. Autoimmune Diseases
- ☰ 7.3.5. Allergies
- ☰ 7.3.5.1. Type I Allergies: Immediate Type
- ☰ 7.3.5.2. Prophylaxis and Therapy of Allergies
-
-
- ☰ 7.4. Plant Defense Systems
- ☰ 7.4.1. Defense Mechanisms of Plants
- ☰ 7.4.2. Economic Applications
-
-
- ☰ 8. Evolution and Biological Diversity
- ☰ 8.1. History of Evolutionary Thought
- ☰ 8.1.1. Evolutionary Theories Through Time
- ☰ 8.1.1.1. Creation Myths
- ☰ 8.1.1.2. Ancient Natural Philosophy
- ☰ 8.1.1.3. Early Scientific Approaches to Descent
- ☰ 8.1.1.4. Mechanism and Vitalism
- ☰ 8.1.1.5. Pioneers of Scientific Evolutionary Theory
- ☰ 8.1.1.6. Darwin’s Theory of Evolution
- ☰ 8.1.1.7. Comparison of Lamarck’s and Darwin’s Theories
-
- ☰ 8.1.2. Ideas on the Origin of Life
- ☰ 8.1.2.1. The “RNA World”
- ☰ 8.1.2.2. The Hypercycle Model
- ☰ 8.1.2.3. Extraterrestrial Origin of Life
-
-
- ☰ 8.2. Evidence for the Evolution of Organisms
- ☰ 8.2.1. Common Origin of All Living Things
- ☰ 8.2.2. Fossils as Evidence for Evolution
- ☰ 8.2.2.1. General Findings from the Fossil Record
-
- ☰ 8.2.3. Transitional Forms
- ☰ 8.2.4. Evidence from Ontogeny
- ☰ 8.2.5. Homology and Analogy
- ☰ 8.2.5.1. Criterion of Position
- ☰ 8.2.5.2. Criterion of Specific Quality
- ☰ 8.2.5.3. Criterion of Intermediate Forms (Continuity)
-
- ☰ 8.2.6. Rudimentary Organs and Atavisms
-
- ☰ 8.3. Evolutionary Factors and Their Effects
- ☰ 8.3.1. The Synthetic Theory of Evolution
- ☰ 8.3.1.1. Mutation and Recombination
- ☰ 8.3.1.2. Adaptive Selection
- ☰ 8.3.1.3. Genetic Drift
- ☰ 8.3.1.4. Isolation and Speciation
-
- ☰ 8.3.2. Further Developments and Alternative Theories
-
- ☰ 8.4. Symbiogenesis
- ☰ 8.4.1. Life Means Living Together
- ☰ 8.4.2. Competition – Symbiosis – Commensalism – Antibiosis
- ☰ 8.4.3. Origin of Eukaryotes from Prokaryotes (Endosymbiotic Theory)
-
- ☰ 8.5. Phylogeny and the Diversity of Life
- ☰ 8.5.1. Patterns of Evolution
- ☰ 8.5.2. Phylogenetic Research
-
- ☰ 8.6. Human Evolution
- ☰ 8.6.1. Relationships Among Primates
- ☰ 8.6.1.1. The Position of Humans in the Natural System
-
- ☰ 8.6.2. Human Fossil Record
- ☰ 8.6.3. Do Human Races Exist?
- ☰ 8.6.3.1. Origin of Modern Humans
-
- ☰ 8.6.4. Cognitive and Cultural Evolution
-
- ☰ 8.7. Classification of Diversity (Systematics)
- ☰ 8.7.1. Domain Archaea
- ☰ 8.7.2. Domain Bacteria
- ☰ 8.7.3. Domain Eukarya
- ☰ 8.7.3.1. 1st Kingdom: Protista
- ☰ 8.7.3.2. 2nd Kingdom: Plantae
- ☰ 8.7.3.3. 3rd Kingdom: Fungi
- ☰ 8.7.3.4. 4th Kingdom: Animalia
-
-
-
- ☰ 9. Behavioral Biology
- ☰ 9.1. Goals and Methods of Behavioral Biology
- ☰ 9.1.1. Subfields of Behavioral Biology
- ☰ 9.1.2. Goals of Behavioral Biology
- ☰ 9.1.3. Methods of Behavior Recording and Analysis
- ☰ 9.1.4. Applied Behavioral Research
-
- ☰ 9.2. Development of Behavior
- ☰ 9.2.1. Ontogeny and Individual Development of Behavior
- ☰ 9.2.2. Behavior of Juvenile Animals
-
- ☰ 9.3. Mechanisms of Behavior
- ☰ 9.3.1. Coordination of Movements
- ☰ 9.3.2. Innate Behavior
- ☰ 9.3.3. Learned Behavior
-
- ☰ 9.4. Adaptiveness of Behavior
- ☰ 9.4.1. Adaptation Strategies
- ☰ 9.4.2. Communication
- ☰ 9.4.3. Social Structures and Forms of Organization
- ☰ 9.4.4. Conflict Behavior
- ☰ 9.4.5. Reproductive Behavior and Parental Care
- ☰ 9.4.6. The Special Status of Humans – An Outdated Concept?
-
-
- ☰ 10. Ecology
- ☰ 10.1. Organisms in Their Environment
- ☰ 10.1.1. Tolerance Range and Ecological Potency
- ☰ 10.1.2. Abiotic Environmental Factors
- ☰ 10.1.2.1. Influence of Water
- ☰ 10.1.2.2. Influence of Light
- ☰ 10.1.2.3. Influence of Mechanical Factors
- ☰ 10.1.2.4. Influence of Soil Factors
-
- ☰ 10.1.3. Biotic Environmental Factors
-
- ☰ 10.2. Structure of the Biosphere
- ☰ 10.2.1. Energy Flow and Nutrient Cycles
- ☰ 10.2.1.1. Carbon Cycle
- ☰ 10.2.1.2. Nitrogen Cycle
- ☰ 10.2.1.3. Phosphorus Cycle
- ☰ 10.2.1.4. Sulfur Cycle
-
- ☰ 10.2.2. Ecosystems
- ☰ 10.2.3. Zonation of the Biosphere
- ☰ 10.2.3.1. Orobiomes – Mountain Ecosystems
- ☰ 10.2.3.2. Azonal Biomes
-
- ☰ 10.2.4. Development and Change of Ecosystems
- ☰ 10.2.5. Forest Ecosystem
- ☰ 10.2.6. Lake Ecosystem
-
- ☰ 10.3. Population Ecology
- ☰ 10.3.1. Growth and Development of a Population
- ☰ 10.3.2. Age Structure of Populations
- ☰ 10.3.3. Regulation of Population Density
-
- ☰ 10.4. Humans and the Biosphere
- ☰ 10.4.1. Development of the World Population
- ☰ 10.4.2. Resources and Management of Land and Seas
- ☰ 10.4.3. Pollution of Air, Water, Soil
- ☰ 10.4.3.1. Air
- ☰ 10.4.3.2. Water
- ☰ 10.4.3.3. Soil
-
- ☰ 10.4.4. Waste and Recycling
-
- ☰ 10.5. Nature and Environmental Protection
- ☰ 10.5.1. Why Protect Nature and the Environment?
- ☰ 10.5.2. Decline of Biological Diversity
- ☰ 10.5.2.1. Climate Change
-
- ☰ 10.5.3. Laws and Measures
- ☰ 10.5.3.1. International Efforts
- ☰ 10.5.3.2. Legislation
- ☰ 10.5.3.3. Protected Areas
-
-
-
Comments
Please login to add a comment.
Don't have an account? Register now!